Skip to main content

Genitourinary Cancer clinical trials at UC Davis

1 research study open to eligible people

Showing trials for
  • A Study of Experimental PET Scan for Renal Cell Carcinoma (kidney cancer)

    open to eligible people ages 21-100

    Metastatic kidney cancer is usually treated with targeted therapy or immunotherapy which is costly and has low response rate. The current standard care is to perform anatomical imaging studies after a few cycles (months) of treatment to evaluate response. This approach exposes many patients to highly toxic, high expensive treatment without any benefit for months and delays initiation of other effective therapies. The goal of this study is to evaluate a parametric PET method that potentially identify response and assess drug efficacy with a few days to weeks of treatment.

    Sacramento, California

Last updated: